CLINICAL ROLE -
Merck and NanoString Announce Clinical Research Collaboration to Develop an Immune-Related Gene Expression Assay for Use in the Development Program for KEYTRUDAÂ® (pembrolizumab)
Merck and NanoString Technologies, Inc. today announced a clinical research collaboration to develop an assay that will optimize immune-related gene expression signatures.
Jack Osbourne and Teva Launch Enhanced You Don't Know Jack About MSÂ® Website Featuring New Multimedia Content
Multiple Sclerosis patient Jack Osbourne unveils new resources to empower others with Multiple Sclerosis to take a more active role in managing disease.
2 Clarke Drive Cranbury, NJ 08512